SCHEMBL3206947

SCHEMBL3206947

N[C@H]1CCOC[C@H]1c1ccc(-c2ccccc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 11/20 0.58
MAOB P27338 9/20 0.58
TAAR1 Q96RJ0 3/20 0.44
MAOA P21397 7/20 0.41
CYP2C19 P33261 4/20 0.41
CYP2B6 P20813 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C9 P11712 2/20 0.41
LMNA P02545 2/20 0.41
CYP3A4 P08684 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
CYP2A6 P11509 1/20 0.41
SLC6A2 P23975 1/20 0.41
HTR2C P28335 1/20 0.41
ADRA1A P35348 1/20 0.41
DRD3 P35462 1/20 0.41
SLC6A3 Q01959 1/20 0.41
KCNH2 Q12809 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3195649 1.00 KDM1A (0.58) KDM1AMAOBTAAR1MAOACYP2C19
SCHEMBL3195645 1.00 KDM1A (0.58) KDM1AMAOBTAAR1MAOACYP2C19
SCHEMBL3195660 1.00 KDM1A (0.58) KDM1AMAOBTAAR1MAOACYP2C19
SCHEMBL3206937 1.00 KDM1A (0.58) KDM1AMAOBTAAR1MAOACYP2C19
SCHEMBL4775521 0.90 MAOB (0.52) KDM1AMAOBTAAR1MAOACYP2C19
SCHEMBL28515035 0.90 MAOB (0.52) KDM1AMAOBTAAR1MAOACYP2C19
SCHEMBL3195739 0.87 KDM1A (0.58) KDM1AMAOBTAAR1MAOACYP2C19
SCHEMBL3197346 0.87 KDM1A (0.58) KDM1AMAOBTAAR1MAOACYP2C19
SCHEMBL3195727 0.87 KDM1A (0.58) KDM1AMAOBTAAR1MAOACYP2C19
SCHEMBL3197364 0.87 KDM1A (0.58) KDM1AMAOBTAAR1MAOACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035865-A1 Sulfonamides and Pharmaceutical Compositions Thereof PFIZER INC 2010-02-11 US disclosed
EP-2142505-A1 SULFONAMIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF Pfizer, Inc. (US) 2010-01-13 EP disclosed
WO-2008120093-A1 SULFONAMIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF PFIZER INC. (US) 2008-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035865-A1 Sulfonamides and Pharmaceutical Compositions Thereof STS, SULT2A1, SULT1A1 KDM1A 1525/4885MAOB 2542/4885TAAR1 3768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.